Imerslund-Gränsbeck Syndrome: systematic review of clinical cases

Authors

  • Ledmar Jovanny Vargas Rodríguez Hospital Universitario San Rafael - Universidad de Boyacá
  • Nicole Espitia Lozano Universidad Pedagógica y Tecnológica de Colombia (UPTC)
  • Hannia Milena de la Peña Triana Universidad Pedagógica y Tecnológica de Colombia (UPTC)
  • Jeimy Lorena Vargas Vargas Universidad Pedagógica y Tecnológica de Colombia (UPTC)
  • Javier Orlando Barón Barón Hospital Universitario San Rafael - Universidad de Boyacá
  • Edwar Jassir Rozo Ortiz Hospital Universitario San Rafael
  • Camila Andrea Acosta Pérez Hospital Universitario San Rafael
  • Juliana Noguera Fonseca Universidad de Boyacá
  • Luis Alberto Ruiz Universidad de Boyacá
  • Camilo Andrés Rivera Perdomo Universidad de Boyacá
  • Marlith Julieth Galeano Fajardo Universidad de Boyacá

DOI:

https://doi.org/10.21615/cesmedicina.6781

Keywords:

Imerslund-Gränsbeck Syndrome, recessive megaloblastic anemia, proteinuria, vitamin B12, cobalamin

Abstract

Introduction: Imerslund-Gränsbeck Syndrome is an unusual congenital disorder that causes a decrease in vitamin B12, megaloblastic anemia and proteinuria without kidney involvement that is caused by a mutation of chromosomes 10 and 14, which determine a defect in the complex receptor vitamin B12-ileal enterocyte intrinsic factor. It was described by Olga Imerslund and Armas Gransbeck. Objective: to characterize the population that has suffered from Imerslund Gränsbeck syndrome. Methodology: systematic review of the clinical case literature. Results: 68 cases were included, in most cases the diagnosis in the first 10 years of life, in which a higher frequency was found in women, and was found to be associated with family history such as consanguinity between parents (14.6%). The most frequent manifestation was paleness (20.9%), followed by vomiting (10.5%) and anorexia (9.8%). Megaloblastic anemia (66.2%) was the most frequent finding and treatment was given with cyanocobalamin (intramuscular or oral) to regulate plasma concentrations of this vitamin. Conclusion: Imerslund-Gränsbeck Syndrome has a low prevalence and occurs more frequently in the European continent, has a predilection for females and is characterized by a decrease in vitamin B12 that may predispose to other disorders such as ataxia and retardation in growth.

Downloads

Download data is not yet available.

Author Biographies

Ledmar Jovanny Vargas Rodríguez, Hospital Universitario San Rafael - Universidad de Boyacá

Programa de Medicina, Universidad de Boyacá, Tunja, Colombia. MD. Departamento de Medicina Interna, Hospital Universitario San Rafael, Tunja, Colombia. 

Nicole Espitia Lozano, Universidad Pedagógica y Tecnológica de Colombia (UPTC)

Residente Medicina Familiar y Comunitaria, Universidad Pedagógica y Tecnológica de Colombia (UPTC), Tunja, Colombia.

Hannia Milena de la Peña Triana, Universidad Pedagógica y Tecnológica de Colombia (UPTC)

Residente Medicina Familiar y Comunitaria, Universidad Pedagógica y Tecnológica de Colombia (UPTC), Tunja, Colombia.

Jeimy Lorena Vargas Vargas , Universidad Pedagógica y Tecnológica de Colombia (UPTC)

Residente Medicina Familiar y Comunitaria, Universidad Pedagógica y Tecnológica de Colombia (UPTC), Tunja, Colombia.

Javier Orlando Barón Barón, Hospital Universitario San Rafael - Universidad de Boyacá

Programa de Medicina, Universidad de Boyacá, Tunja, Colombia. MD. Departamento de Medicina Interna, Hospital Universitario San Rafael, Tunja, Colombia.

Edwar Jassir Rozo Ortiz, Hospital Universitario San Rafael

MD. Departamento de Medicina Interna, Hospital Universitario San Rafael, Tunja, Colombia.

Camila Andrea Acosta Pérez, Hospital Universitario San Rafael

MD. Hospital Universitario San Rafael, Tunja, Colombia.

Juliana Noguera Fonseca, Universidad de Boyacá

Programa de Medicina, Universidad de Boyacá, Tunja, Colombia.

Luis Alberto Ruiz, Universidad de Boyacá

Programa de Medicina, Universidad de Boyacá, Tunja, Colombia.

Camilo Andrés Rivera Perdomo, Universidad de Boyacá

Programa de Medicina, Universidad de Boyacá, Tunja, Colombia.

Marlith Julieth Galeano Fajardo, Universidad de Boyacá

Programa de Medicina, Universidad de Boyacá, Tunja, Colombia. 

References

Huemer M, Baumgartner MR. The clinical presentation of cobalamin-related disorders: From acquired deficiencies to inborn errors of absorption and intracellular pathways. J Inherit Metab Dis. 2019;42(4):686–705.

Udagawa T, Harita Y, Miura K, Mitsui J, Ode KL, Morishita S, et al. Amnionless-mediated glycosylation is crucial for cell surface targeting of cubilin in renal and intestinal cells. Sci Rep 2018;8(1).

Kozyraki R, Cases O. Vitamin B12 absorption: mammalian physiology and acquired and inherited disorders. Biochimie. 2013;95(5):1002–7.

Storm T, Zeitz C, Cases O, Amsellem S, Verroust PJ, Madsen M, et al. Detailed investigations of proximal tubular function in Imerslund-Gräsbeck syndrome. BMC Med Genet. 2013;14(1):111.

Tanner SM, Sturm AC, Baack EC, Liyanarachchi S, de la Chapelle A. Inherited cobalamin malabsorption. Mutations in three genes reveal functional and ethnic patterns. Orphanet J Rare Dis. 2012;7(1):56.

Watkins D, Rosenblatt DS. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet. 2011;157C (1):33–44.

Gräsbeck R. Hooked to vitamin B12 since 1955: a historical perspective. Biochimie. 2013;95(5):970–5.

Beech CM, Liyanarachchi S, Shah NP, Sturm AC, Sadiq MF, de la Chapelle A, et al. Ancient founder mutation is responsible for Imerslund-Gräsbeck Syndrome among diverse ethnicities. Orphanet J Rare Dis. 2011;6(1):74.

Scully C, Langdon J, Evans J. Marathon of eponyms: 9 Imerslund-Grasbeck syndrome (Juvenile pernicious anaemia). Oral Dis. 2010;16(2):219–20.

Fyfe JC, Madsen M, Højrup P, Christensen EI, Tanner SM, de la Chapelle A, et al. The functional cobalamin (vitamin B12)-intrinsic factor receptor is a novel complex of cubilin and amnionless. Blood. 2004;103(5):1573–9.

Namour F, Dobrovoljski G, Chery C, Audonnet S, Feillet F, Sperl W, et al. Luminal expression of cubilin is impaired in Imerslund-Grasbeck syndrome with compound AMN mutations in intron 3 and exon 7. Haematologica. 2011;96(11):1715–9.

Gräsbeck R. Imerslund-Gräsbeck syndrome (selective vitamin B12 malabsorption with proteinuria). Orphanet J Rare Dis. 2006;1(1):17.

Whitehead VM. Acquired and inherited disorders of cobalamin and folate in children. Br J Haematol. 2006;134(2):125–36.

Nielsen R, Christensen EI. Proteinuria and events beyond the slit. Pediatr Nephrol. 2010;25(5):813–22.

Bor MV, Cetin M, Aytaç S, Altay C, Nexo E. Nonradioactive vitamin B12 absorption test evaluated in controls and in patients with inherited malabsorption of vitamin B12. Clin Chem. 2005;51(11):2151–5.

Larsen C, Etzerodt A, Madsen M, Skjødt K, Moestrup SK, Andersen CBF. Structural assembly of the megadalton-sized receptor for intestinal vitamin B12 uptake and kidney protein reabsorption. Nat Commun. 2018;9(1):5204.

Arunath V, Hoole TJ, Rathnasri A, Muthukumarana O, Kumarasiri IM, Liyanage ND, et al. A child with Imerslund-Gräsbeck syndrome concealed by co-existing α-thalassaemia presenting with subacute combined degeneration of the spinal cord: a case report. BMC Pediatr. 2021;21(1):41.

Watkins D, Rosenblatt DS. Immunodeficiency and inborn disorders of vitamin B12 and folate metabolism. Curr Opin Clin Nutr Metab Care. 2020;23(4):241–6.

Gurlek Gokcebay D, Akpinar Tekgunduz S, Cavdarli B. Imerslund-Gräsbeck Syndrome presenting with microangiopathic hemolytic anemia in a child. Eur J Med Genet. 2020;63(6):103880.

Bargehr C, Crazzolara R. Cabot rings and other peripheral blood features of Imerslund-Gräsbeck syndrome. Br J Haematol. 2020;191(1):11.

Pacitto A, Prontera P, Stangoni G, Stefanelli M, Ceppi S, Cerri C, et al. Imerslund-Gräsbeck syndrome in an infant with a novel intronic variant in the AMN gene: A case report. Int J Mol Sci. 2019;20(3):527.

Montgomery E, Sayer JA, Baines LA, Hynes AM, Vega-Warner V, Johnson S, et al. Novel compound heterozygous mutations in AMN cause Imerslund-Gräsbeck syndrome in two half-sisters: a case report. BMC Med Genet. 2015;16(1):35.

Aparicio López C, de Lucas Collantes C, Jimenez F, Antón Martín P. Síndrome de Imerslund-Gräsbeck: anemia megaloblástica con proteinuria. An Pediatr (Barc). 2014;80(2): e62-3.

Shivbalan S, Srinath MV. Reversible skin hyperpigmentation in Imerslund-Grasbeck syndrome. Indian Pediatr. 2013;50(10):973–4.

De Filippo G, Rendina D, Rocco V, Esposito T, Gianfrancesco F, Strazzullo P. Imerslund-Gräsbeck syndrome in a 25-month-old Italian girl caused by a homozygous mutation in AMN. Ital J Pediatr. 2013;39(1):58.

Densupsoontorn N, Sanpakit K, Vijarnsorn C, Pattaragarn A, Kangwanpornsiri C, Jatutipsompol C, et al. Imerslund-Gräsbeck syndrome: New mutation in amnionless: Imerslund-Gräsbeck syndrome in Thailand. Pediatr Int. 2012;54(3): e19-21.

Boina Abdallah A, Ogier de Baulny H, Kozyraki R, Passemard S, Fenneteau O, Lebon S, et al. How can cobalamin injections be spaced in long-term therapy for inborn errors of vitamin B (12) absorption? Mol Genet Metab. 2012;107(1–2):66–71.

Levin-Iaina N, Dinour D, Morduchowicz G, Ganon L, Holtzman EJ. Molecular study of proteinuria in patients treated with B₁₂ supplements: do not forget megaloblastic anemia type 1. Nephron Clin Pract. 2011;118(2):c67-71.

Storm T, Emma F, Verroust PJ, Hertz JM, Nielsen R, Christensen EI. A patient with cubilin deficiency. N Engl J Med. 2011;364(1):89–91.

Choquet P, Levrat V, Pondarre C, Vianney C, Guffon N. Maladie d’Imerslund-Gräsbeck. Arch Pediatr. 2009;16(12):1559–61.

Madhavan S, Vijayakumar M, Rajajee S, Nammalwar BR. Síndrome de Imerslund-Grasbeck: asociación con diabetes mellitus. Pediatra indio. 2009 Marzo; 46(3):251-3. PMID: 19346573.

García Jiménez MC, Baldellou Vázquez A, Calvo Martín MT, Pérez-Lungmus G, López Pisón J. Déficit de cobalamina hereditario juvenil causado por mutaciones en el gen GIF [Hereditary juvenile cobalamin deficiency due to mutations in GIF gene]. An Pediatr (Barc). 2008 Jul;69(1):56-8. Spanish. doi: 10.1157/13124221. PMID: 18620679.

Hauck FH, Tanner SM, Henker J, Laass MW. Imerslund-Gräsbeck syndrome in a 15-year-old German girl caused by compound heterozygous mutations in CUBN. Eur J Pediatr. 2008 Jun;167(6):671-5. doi: 10.1007/s00431-007-0571-3. Epub 2007 Aug 1. PMID: 17668238.

Broides A, Yerushalmi B, Levy R, Hadad N, Kaplun N, Tanner SM, Chapelle Ade L, Levy J. Imerslund-Grasbeck syndrome associated with recurrent aphthous stomatitis and defective neutrophil function. J Pediatr Hematol Oncol. 2006 Nov;28(11):715-9. doi: 10.1097/01.mph.0000243656.25938.7b. PMID: 17114957.

Tanner SM, Li Z, Perko JD, Oner C, Cetin M, Altay C, Yurtsever Z, David KL, Faivre L, Ismail EA, Gräsbeck R, de la Chapelle A. Hereditary juvenile cobalamin deficiency caused by mutations in the intrinsic factor gene. Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4130-3. doi: 10.1073/pnas.0500517102. Epub 2005 Feb 28. PMID: 15738392; PMCID: PMC554821.

Eitenschenck L, Armari-Alla C, Plantaz D, Pagnier A, Ducros V. Décompensation tardive d'une maladie d'Imerslund-Grasbëck [Belated decompensation of an Imerslund-Grasbeck disease]. Arch Pediatr. 2005 Dec;12(12):1729-31. French. doi: 10.1016/j.arcped.2005.09.011. Epub 2005 Nov 8. PMID: 16289772.

Carmel R, Green R, Rosenblatt DS, Watkins D. Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program. 2003:62-81. doi: 10.1182/asheducation-2003.1.62. PMID: 14633777.

Published

2022-11-16

How to Cite

Vargas Rodríguez, L. J., Espitia Lozano, N., de la Peña Triana, H. M., Vargas Vargas , J. L., Barón Barón, J. O., Rozo Ortiz, E. J., … Galeano Fajardo, M. J. (2022). Imerslund-Gränsbeck Syndrome: systematic review of clinical cases. CES Medicina, 36(3), 26–37. https://doi.org/10.21615/cesmedicina.6781

Issue

Section

Artículo original de investigación científica o tecnológica
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views